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Presenting Symptoms in Men and Women Diagnosed With Myocardial
Infarction Using Sex-Speciﬁc Criteria
Amy V. Ferry, BSc;* Atul Anand, MD, PhD;* Fiona E. Strachan, PhD; Leanne Mooney, MD; Stacey D. Stewart, MN; Lucy Marshall, BSc;
Andrew R. Chapman, MD, PhD; Kuan Ken Lee, MD; Simon Jones, MD; Katherine Orme, MD; Anoop S. V. Shah, MD, PhD;
Nicholas L. Mills, MD, PhD
Background-—Sex-speciﬁc criteria are recommended for the diagnosis of myocardial infarction, but the impact of these on
presenting characteristics is unknown.
Methods and Results-—We evaluated patient-reported symptoms in 1941 patients (39% women) with suspected acute
coronary syndrome attending the emergency department in a substudy of a prospective trial. Standardized criteria deﬁned
typical and atypical presentations based on pain nature, location, radiation, and additional symptoms. Diagnosis of
myocardial infarction was adjudicated using a high-sensitivity cardiac troponin I assay with sex-speciﬁc thresholds (>16 ng/L
women, >34 ng/L men). Patients identiﬁed who were missed by the contemporary assay with a uniform threshold (≥50 ng/L)
were reclassiﬁed by this approach. Type 1 myocardial infarction was diagnosed in 16% (184/1185) of men and 12% (90/756)
of women, with 9 (5%) men and 27 (30%) women reclassiﬁed using high-sensitivity cardiac troponin I and sex-speciﬁc
thresholds. Chest pain was the presenting symptom in 91% (1081/1185) of men and 92% (698/756) of women. Typical
symptoms were more common in women than in men with myocardial infarction (77% [69/90] versus 59% [109/184];
P=0.007), and differences were similar in those reclassiﬁed (74% [20/27] versus 44% [4/9]; P=0.22). The presence of ≥3
typical features was associated with a positive likelihood ratio for the diagnosis of myocardial infarction in women (positive
likelihood ratio, 1.18; 95% CI, 1.03–1.31) but not in men (positive likelihood ratio 1.09; 95% CI, 0.96–1.24).
Conclusions-—Typical symptoms are more common and have greater predictive value in women than in men with myocardial
infarction whether or not they are diagnosed using sex-speciﬁc criteria.
Clinical Trial Registration-—URL: http://www.clinicaltrials.gov. Unique identiﬁer NCT01852123. ( J Am Heart Assoc. 2019;8:
e012307. DOI: 10.1161/JAHA.119.012307.)
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A n evaluation of clinical symptoms is a major part of therisk stratiﬁcation of patients presenting to the emer-
gency department with suspected acute coronary syndrome.
The accurate interpretation of clinical symptoms has implica-
tions for patient triage, treatment, and subsequent manage-
ment.
The last 2 revisions of the universal deﬁnition of myocardial
infarction1,2 recommend the use of sex-speciﬁc troponin
thresholds for the diagnosis of myocardial infarction. Use of
sex-speciﬁc thresholds has identiﬁed a population of patients
with previously unrecognized myocardial infarction.3 These
patients would not have been included in previous study
populations investigating sex differences in symptom presen-
tation. Atypical symptom presentations associated with
myocardial infarction in women are thought to contribute to
lower rates of diagnosis and treatment, and worse outcomes
compared with men with myocardial infarction.4–7 Interna-
tional guidelines reinforce the view that women are more
likely to present with atypical symptoms, such as epigastric
pain, dyspepsia, or breathlessness.5,8 It is unknown how
identiﬁcation of these newly identiﬁed patients will impact the
symptom proﬁle of patients with myocardial infarction.
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While studies reporting sex differences in symptom
presentation can boast large study populations,9–11 they are
limited by the use of retrospective data collection from clinical
records or registries of patients with conﬁrmed myocardial
infarction and therefore are at risk of selection bias. In
contrast, studies that evaluated patients with suspected acute
coronary syndrome report there are more similarities than
differences in symptom presentation between men and
women.12,13 Additionally, studies performed before the third
universal deﬁnition of myocardial infarction may not be
representative of current practice where the use of sex-
speciﬁc diagnostic thresholds for cardiac troponin are
recommended.1,2
Women with myocardial infarction are at risk of under-
diagnosis and undertreatment if correct symptom presenta-
tions are not recognized. Our aim was to prospectively
evaluate the frequency and predictive value of patient-
reported symptoms in men and women with suspected acute
coronary syndrome and to determine whether symptoms
differ when the diagnosis of myocardial infarction is based on
sex-speciﬁc criteria.
Methods
Study Population
Patients with suspected acute coronary syndrome were
recruited from the emergency department of the Royal
Inﬁrmary of Edinburgh, a tertiary care hospital in Scotland,
between June 1, 2013, and March 3, 2017, into a substudy of
the High-STEACS (High-Sensitivity Troponin in the Evaluation
of Patients with Acute Coronary Syndrome) trial. All patients
over 18 years of age in whom the attending clinician
requested cardiac troponin for suspected acute coronary
syndrome were eligible for inclusion. We did not enroll
patients with ST-segment elevation myocardial infarction,
those who were unable to provide consent, or those with
previous involvement in the trial. This clinical trial and
associated substudies were registered (ClinicalTrials.gov
number NCT01852123), approved by the National Research
Ethics Committee, and conducted in accordance with the
Declaration of Helsinki. We do not currently have approval to
share the study data set. However, it is our intention to seek
additional approvals to share a deidentiﬁed data set.
Baseline Characteristics
Patient baseline characteristics, including prior medical
history, cardiovascular risk factors, clinical observations, and
12-lead electrocardiography, were obtained from a case
record form, and the electronic patient record. Hyperlipidemia
and hypertension were deﬁned as a history of the condition,
or by the use of lipid-lowering or antihypertensive therapies,
respectively. Ischemic heart disease was deﬁned as a history
of angina, prior myocardial infarction, or prior coronary
revascularization. The criteria used to deﬁne ST-segment
elevation, ST-segment depression, left bundle branch block,
and T-wave inversion were based on international guidelines.2
Myocardial ischemia was based on a global assessment of the
ECG and the presence of any dynamic changes on serial
testing.
Symptom Characterization
Patients were interviewed in the emergency department. The
presenting symptoms as reported by the patient were
documented on a data collection form (Figure S1) by a
research nurse from the trial team blinded to the troponin
concentration. If patients reported >1 symptom (eg, chest
pain and dyspnea), both symptoms were recorded as a
presenting symptom. Presenting symptoms were then clas-
siﬁed as typical or atypical, as described by Greenslade and
colleagues.14 Typical pain was classiﬁed in patients reporting
the presence of chest, arm, or jaw pain with descriptors of
Clinical Perspective
What Is New?
• The fourth universal deﬁnition of myocardial infarction now
recommends the use of sex-speciﬁc diagnostic criteria, but
the impact of these criteria on the presentation and clinical
features of men and women with suspected acute coronary
syndrome is unknown.
• Many previous studies have relied on clinician-reported
symptoms that may be susceptible to ascertainment bias,
whereas we prospectively recorded patient-reported symp-
toms in 1941 patients with suspected acute coronary
syndrome.
• We report that typical symptoms are more common and
have greater predictive value in women than in men with
myocardial infarction, whether diagnosed using sex-speciﬁc
or uniform criteria.
What Are the Clinical Implications?
• International guidelines currently state that women with
myocardial infarction commonly present with atypical
symptoms, which is contrary to evidence supported in this
study.
• The accurate interpretation of clinical symptoms has
implications for patient triage, treatment, and subsequent
management.
• Women with myocardial infarction are at risk of underdiag-
nosis and undertreatment if correct symptom presentations
are not recognized.
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dull, heavy, tight, pressure, ache, squeezing, crushing, or
gripping. Atypical pain was classiﬁed in patients reporting
epigastric or back pain or pain that was burning, stabbing,
indigestion-like, or any other pain description or presenta-
tion.14 Guidelines also state that radiation of pain and the
presence of associated symptoms form part of a typical
presentation8; therefore the presence of radiation (right arm,
left arm, neck, jaw, back) and presence of any associated
feature (nausea, vomiting, sweating, dyspnea, palpitations)
was also documented.
High-Sensitivity Cardiac Troponin I Assay
The Abbott ARCHITECTSTAT high-sensitivity cardiac troponin I
assay (Abbott Laboratories, Abbott Park, IL) is a 2-step
chemoluminescent assay with a limit of detection of 1.2 ng/L
and coefﬁcient of variation of <10% at 6 ng/L.15 Assay
performance has been independently validated under routine
laboratory working conditions, with a reported interlaboratory
coefﬁcient of variation of 12.6% at 3.5 ng/L across 33
instruments.16 The upper reference limit 99th percentiles
were determined in 4590 samples from healthy individuals as
16 ng/L for women and 34 ng/L in men,17 and from
December 10, 2013, onwards these thresholds were used
in clinical practice.
Diagnostic Adjudication
The ﬁnal diagnosis was adjudicated independently by 2
physicians (A.A./K.L.), with consensus from a third physician
(A.S.) where there was discrepancy following review of all
clinical information, both noninvasive and invasive investiga-
tions, and outcomes from presentation to 30 days. All patients
with cardiac troponin I concentrations above the sex-speciﬁc
99th percentile were adjudicated and classiﬁed as having type 1
myocardial infarction, type 2 myocardial infarction, or myocar-
dial injury, in accordance with the third universal deﬁnition of
myocardial infarction as previously reported.16 Type 1 myocar-
dial infarction was deﬁned as myocardial necrosis (any high-
sensitivity cardiac troponin I concentration above the 99th
percentile with a rise and/or fall in concentration where serial
testing was performed) in the context of a presentation with
symptoms suggestive of acute coronary syndrome or evidence
of myocardial ischemia on the ECG or subsequent invasive or
noninvasive testing. Patients with myocardial necrosis and
symptoms or signs of myocardial ischemia due to increased
oxygen demand or decreased supply (eg, tachyarrhythmia,
hypotension, or anemia) secondary to an alternative pathology
were classiﬁed as type 2 myocardial infarction. Myocardial
injury was deﬁned if high-sensitivity cardiac troponin I concen-
trations were above the 99th percentile in the absence of any
clinical features of myocardial ischemia. Agreement for a
diagnosis of type 1 myocardial infarction was good (j=0.77;
95% CI, 0.69–0.84).
Participants diagnosed with myocardial injury identiﬁed by
the high-sensitivity assay with sex-speciﬁc thresholds
(>16 ng/L for women and >34 ng/L for men) who would
have been unrecognized with the previous generation of
contemporary cardiac troponin I assays (those with high-
sensitivity troponin I concentrations of 17–49 ng/L for
women and 35–49 ng/L for men) were “reclassiﬁed.” Iden-
tiﬁcation of this group of patients permits exploration of a
previously unstudied group of patients because of the
limitations of previous assay technology.
Statistical Analysis
Baseline characteristics are summarized as mean (SD) or
median (interquartile range) as appropriate. We compared
presenting chest pain characteristics of men andwomen for the
whole population, for those with type 1 myocardial infarction,
and for those with type 2 myocardial infarction, using chi-
squared tests for categorical data. Likelihood ratios (LRs) with
95%CIs were calculated to assess the predictive value of typical
symptom characteristics (pain nature, pain location, radiation,
additional features) for the diagnosis of type 1 myocardial
infarction in men and women. An LR summarizes how many
timesmore likely patients with a particular symptom feature are
to have a diagnosis of type 1 myocardial infarction than those
without the feature. An LR of >1 indicates that the feature is
associated with the presence of type 1 myocardial infarction,
and<1 indicates that the feature is associated with the absence
of type 1 myocardial infarction. Multivariate logistic regression
modeling was then used to calculate odds ratios with 95% CIs
for the number of typical features present based on the
following categorization. Symptom presentations were catego-
rized as having between 0 and 4 typical features on the basis of
the pain nature (dull, heavy, tight, pressure, ache, squeezing,
crushing, or gripping), location (central, left, or right chest; arm;
or jaw), radiation (right arm, left arm, neck, jaw, back, other),
and the presence of associated symptoms (nausea, vomiting,
sweating, dyspnea, palpitations, other). This model was
adjusted for age, history of ischemic heart disease, diabetes
mellitus, hypertension, smoking (current or ex-smoker),
ischemia on the presenting 12-lead ECG and an atypical feature
variable (in either nature or location). All analyses were
performed using R (Version 3.2.2).
Results
Baseline Characteristics
We recruited a total study population of 1941 patients (39%
women) with suspected acute coronary syndrome (756
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women, 62.814.0 years; 1185 men, 60.714.3 years;
Table 1). A total of 388 (20%) patients (152/756 women
and 236/1185 men) had a troponin concentration above the
upper reference limit. The adjudicated diagnosis was type 1
myocardial infarction in 11.9% (90/756) of women and 15.5%
(184/1185) of men. Men with suspected acute coronary
syndrome had a higher burden of established cardiovascular
risk factors than women, including higher rates of diabetes
mellitus, hyperlipidemia, known ischemic heart disease, and
cigarette smoking. A positive family history was more
common among women. However, the frequency of cardio-
vascular risk factors was similar in men and women with a
diagnosis of type 1 myocardial infarction, with only previous
coronary artery bypass grafting and cigarette smoking more
common in men than women (Table S1).
Symptom Characteristics
Chest pain was the most common presenting symptom,
reported by 92% (698/756) of women and 91% (1081/1185)
of men with suspected acute coronary syndrome (P=0.439;
Table 2). Pain with typical nature descriptors, the presence of
radiation, and the presence of additional symptoms were all
more common in women with suspected acute coronary
syndrome (P<0.04 for all; Table 2). Women, compared with
men, more often reported palpitations as a presenting
symptom (11% versus 7%; Table S2). Women were also more
likely to report that their pain radiated to the left arm (36%
versus 31%), the back (31% versus 17%), or to the neck or jaw
(28% versus 20%) than were men, and were more likely to
report associated nausea (34% versus 22%; Table S2).
Chest pain remained the most common presenting symp-
tom for women and men with a diagnosis of type 1 myocardial
infarction (93% and 93%; P=1.00; Table 2). The frequency of
typical and atypical features of chest pain in women and men
with and without an adjudicated diagnosis of type 1 myocar-
dial infarction is illustrated in Figure 1. Women with type 1
myocardial infarction reported pain with more typical nature
features than did men (81% versus 64%; P=0.005; Table 2),
and pain was classiﬁed overall as typical more commonly in
women (77% versus 59%; P=0.007; Table 2).
The adjudicated diagnosis was type 2 myocardial infarction
in 5.1% (39/756) of women and 3.2% (38/1185) of men
(Table 1). Chest pain remained the most common presenting
symptom for women and men with type 2 myocardial
infarction (82% and 87%, respectively) but was less common
than in those with type 1 myocardial infarction (Table S3).
Overall, patients with type 2 myocardial infarction were less
likely to have typical chest pain location (82% versus 91%;
P=0.04), less likely to have radiating pain (49% versus 67%;
P=0.006), and more likely to present with palpitations (19%
versus 4%; P<0.001) when compared with patients with type 1
Table 1. Baseline Characteristics of Study Population
Suspected Acute Coronary
Syndrome (n=1941)
P ValueMen Women
No. of participants, n (%) 1185 (61) 756 (39) <0.001
Age, y, mean (SD) 60.7 (14.3) 62.8 (14.0) 0.002
Past medical history
Smoking, n (%) 725 (61.2) 379 (50.1) <0.001
Diabetes mellitus, n (%) 198 (16.7) 89 (11.8) 0.003
Hypertension, n (%) 472 (39.8) 301 (39.8) 1.00
Hyperlipidemia, n (%) 510 (43.0) 258 (34.1) <0.001
Family history, n (%) 534 (45.1) 393 (52.0) 0.003
Angina, n (%) 381 (32.2) 203 (26.9) 0.015
Myocardial infarction, n (%) 327 (27.6) 134 (17.7) <0.001
Previous PCI, n (%) 265 (22.4) 101 (13.4) <0.001
Ischemic heart
disease, n (%)
500 (42.2) 259 (34.3) 0.001
Previous CABG, n (%) 103 (8.7) 14 (1.9) <0.001
Heart failure, n (%) 43 (3.6) 23 (3.0) 0.571
Cerebrovascular
disease, n (%)
81 (6.8) 39 (5.2) 0.162
Peripheral vascular
disease, n (%)
28 (2.4) 11 (1.5) 0.221
Medications at presentation
Aspirin, n (%) 440 (37.1) 215 (28.4) <0.001
Clopidogrel, n (%) 171 (14.4) 79 (10.4) 0.013
Prasugrel, n (%) 9 (0.8) 2 (0.3) 0.269
Ticagrelor, n (%) 1 (0.1) 1 (0.1) 1.00
Warfarin, n (%) 71 (6.0) 35 (4.6) 0.236
Beta-blocker, n (%) 336 (28.4) 186 (24.6) 0.078
ACE inhibitor or ARB, n (%) 389 (32.8) 195 (25.8) 0.001
Calcium-channel
blocker, n (%)
158 (13.3) 84 (11.1) 0.169
Nitrate, n (%) 243 (20.5) 126 (16.7) 0.041
Nicorandil, n (%) 63 (5.3) 28 (3.7) 0.126
Diuretic, n (%) 168 (14.2) 128 (16.9) 0.114
PPI, n (%) 370 (31.2) 268 (35.4) 0.06
Statin, n (%) 555 (46.8) 270 (35.7) <0.001
NOAC, n (%) 12 (1.0) 13 (1.7) 0.254
ECG
Myocardial ischemia 143 (12.1) 74 (9.8) 0.139
ST-segment elevation 50 (4.2) 8 (1.1) <0.001
ST-segment depression 74 (6.2) 38 (5.0) 0.306
Left bundle branch block 47 (4.0) 29 (3.8) 0.981
T-wave inversion 181 (15.3) 120 (15.9) 0.771
Continued
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myocardial infarction (Table S3). Consistent with our ﬁndings
in those with type 1 myocardial infarction, typical symptom
features (pain with typical nature descriptors, the presence of
radiation, and the presence of additional symptoms) were
more frequently reported in women than in men with type 2
myocardial infarction.
Diagnostic Performance of Pain Characteristics
Typical pain nature symptoms were predictive of type 1
myocardial infarction in women (LR+, 1.18; 95% CI, 1.04–
1.31) but not men (LR+, 0.97; 95% CI, 0.86–1.09; Figure 2).
Conversely, radiation of pain was predictive of myocardial
infarction in men (LR+, 1.39; 95% CI, 1.22–1.56) but not
women (LR+, 1.13; 95% CI, 0.97–1.28). In women, the
combination of ≥3 typical features (pain nature, pain location,
radiation, associated symptoms) was associated with a
signiﬁcant positive LR for the diagnosis of type 1 myocardial
infarction (LR+, 1.18; 95% CI, 1.03–1.31), but this relationship
was not present in men (LR+, 1.09; 95% CI, 0.96–1.24).
Using logistic regression modeling, odds ratios were calcu-
lated for combinations of typical features to predict a diagnosis
of type 1 myocardial infarction compared with 0 or 1 feature
being present (0 and1were combinedbecauseof lownumbers).
Eachsubsequent additionof a typical feature increased theodds
of type 1myocardial infarction in women, but symptoms had no
associated predictive value in men (Table 3). This association
remained even after adjusting for baseline characteristics
including age and comorbidity.
Sex-Speciﬁc Diagnostic Thresholds
The use of a high-sensitivity cardiac troponin I assay and sex-
speciﬁc diagnostic thresholds increased the number of
patients diagnosed with type 1 myocardial infarction by 30%
Table 1. Continued
Suspected Acute Coronary
Syndrome (n=1941)
P ValueMen Women
Physiological parameters
Heart rate, bpm,
mean (SD)
75 (20) 78 (20) 0.001
Systolic BP, mm Hg,
mean (SD)
137 (26) 140 (29) 0.04
High-sensitivity cardiac troponin I concentration
At presentation, ng/L,
median (IQR)
4 (2–13) 2 (1–7) <0.001
At peak, ng/L,
median (IQR)
5 (2–20) 3 (1–9) <0.001
Adjudicated diagnosis
Type 1 myocardial
infarction, n (%)
184 (15.5) 90 (11.9) 0.03
Type 2 myocardial
infarction, n (%)
38 (3.2) 39 (5.1)
Myocardial injury, n (%) 13 (1.1) 18 (2.4)
Unable to classify, n (%) 1 (0.1) 5 (0.7)
Presented as mean (SD), median (interquartile range [IQR]), or number (%). ACE indicates
angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BP, blood pressure;
CABG, coronary artery bypass grafting; NOAC, novel oral anticoagulants; PCI,
percutaneous coronary intervention; PPI, proton pump inhibitor.
Table 2. Presenting Symptom Features of the Study Population
Suspected Acute Coronary Syndrome
P Value
Type 1 Myocardial Infarction
P ValueMen (n=1185) Women (n=756) Men (n=184) Women (n=90)
Presenting symptom
Chest pain, n (%) 1081 (91.2) 698 (92.3) 0.439 171 (92.9) 84 (93.3) 1.00
Symptom feature
Typical nature,* n (%) 772 (65.1) 532 (70.4) 0.019 117 (63.6) 73 (81.1) 0.005
Typical location,† n (%) 1068 (90.1) 683 (90.3) 0.937 165 (89.7) 84 (93.3) 0.445
Radiation (any), n (%) 586 (49.5) 491 (64.9) <0.001 119 (64.7) 65 (72.2) 0.266
Additional symptoms, n (%) 657 (55.4) 456 (60.3) 0.038 94 (51.1) 56 (62.2) 0.107
Symptom classification
Typical pain‡ 719 (61) 489 (65) 0.084 109 (59) 69 (77) 0.007
Atypical pain§ 466 (39) 267 (35) 75 (41) 21 (23)
Symptoms compared between men and women using chi-squared tests for categorical data.
*Typical nature is pain with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing, or gripping.
†Typical location is chest (left, right, or center), arm, or jaw. Location data missing in 6.6% of patients with chest pain.
‡Typical pain classiﬁed in any patient who described pain of chest, arm, or jaw, with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing, or gripping.
§Atypical pain classiﬁed in any patient who described epigastric or back pain or pain that was burning, stabbing, indigestion-like, or any other pain description or presentation.
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(27/90) in women and 4.9% (9/184) in men (P<0.001). The
symptoms reported by patients reclassiﬁed using this
approach were similar to those identiﬁed by the contemporary
assay with a uniform threshold (Table S4).
Discussion
Clinical symptoms are a major part of risk stratiﬁcation for
patients presenting to the emergency department with
suspected acute coronary syndrome. The subject of sex
differences in presenting symptoms of acute coronary syn-
dromes has led to multiple review articles and research studies
addressing this issue without resolution.7,9–13,18–22 Interna-
tional guidelines continue to state that atypical symptom
presentations are more common in women than in men.5,8
We aimed to establish the presenting symptoms of
patients with myocardial infarction in an emergency depart-
ment setting, using sex-speciﬁc diagnostic criteria and direct
Figure 1. Radar plot showing frequency of typical and atypical pain descriptors. Frequency of typical and atypical descriptors of pain, stratiﬁed
by sex, in those with myocardial infarction (A, n=274) and without myocardial infarction (B, n=1667). Men are represented in blue; women are
represented in red.
Figure 2. Positive likelihood ratios for the diagnosis of type 1 myocardial infarction of typical clinical features in men and women. Forest plot
of the positive likelihood ratios and 95% CIs of 4 clinical features (pain nature, pain location, radiation, associated symptoms) in predicting the
diagnosis of myocardial infarction.
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patient interview at the time of presentation. We report 2
major ﬁndings. First, women with type 1 myocardial infarction
reported more typical symptoms than did men. Second, while
individual typical pain features had a similar likelihood for
predicting type 1 myocardial infarction in women and men,
the cumulative effect of between 1 and 4 typical pain features
predicted a diagnosis of type 1 myocardial infarction more
strongly in women than in men even after adjusting for
baseline characteristics including age and comorbidity.
Our study has several strengths. We used a prospective
cohort of patients with diagnosis of myocardial infarction
informed by the independent adjudication of 2 cardiologists.
Diagnosis was based on a high-sensitivity cardiac troponin I
assay with sex-speciﬁc diagnostic thresholds as recom-
mended by the latest international guidelines.1,2 Data on
the presenting symptoms were collected prospectively
through direct patient interview, by an independent research
team, at the time of presentation in the emergency depart-
ment, and before the patient was informed of his or her
diagnosis. Symptoms were classiﬁed using standardized
deﬁnitions of typical and atypical pain.14
Our ﬁndings add to those from previous studies undertaken
in an emergency department population.12,13,20–22 All disagree
with the contention in clinical guidelines that atypical symptom
presentations occur more commonly in women. Milner and
colleagues observed that typical symptoms were more com-
mon in women, and these symptoms were more predictive of
myocardial infarction in women in a population of patients with
suspected acute coronary syndrome in a US emergency
department.22 By enrolling patients with suspected acute
coronary syndrome before the initial diagnosis, we reduce the
risk of selection bias that may compromise ﬁndings in cohorts
enrolled once the diagnosis of myocardial infarction is
conﬁrmed. Studies that rely on patient registries or popula-
tions with conﬁrmed myocardial infarction risk excluding many
symptom presentations. Furthermore, studies performed
before the third universal deﬁnition of myocardial infarction2
may not be representative of current practice in which the use
of sex-speciﬁc diagnostic thresholds are recommended.
In our study we adjudicated the diagnosis of myocardial
infarction using sex-speciﬁc thresholds.We observed that 1 in 3
women with a diagnosis of type 1 myocardial infarction were
only identiﬁed using a high-sensitivity cardiac troponin I assay
with sex-speciﬁc thresholds. This approach is now endorsed by
the fourth universal deﬁnition of myocardial infarction1 and will
substantially increase the number of women diagnosed with
myocardial infarction. Interestingly, women reclassiﬁed by this
approach were as likely to present with typical chest pain as
those identiﬁed using a conventional assay with a uniform
diagnostic threshold for both men and women.
We used the standardized deﬁnition of typical and atypical
symptoms offered by Greenslade and colleagues14 to classify
patient presentations into these categories. Many previous
studies did not use standardized deﬁnitions and have
categorized the presenting symptom differently with terms
such as chest discomfort and chest pressure considered to be
distinct from chest pain. This may account for our high
percentage of patients presenting with chest pain, as we have
considered all such terms to indicate the presence of chest
pain, agreeing with Kreatsoulas and colleagues23 that these
terms are a function of sex-related language rather than
differences in symptom presentation. Abstracting symptom
presentation from medical records may further dilute such
terms, as they are translated into medical terminology at the
discretion of the attending clinician. A term such as chest
discomfort may be translated into the absence of chest pain,
rendering the presentation atypical.
We view patient-reported data collection as the gold
standard and superior to that gained from medical record
review. Data were collected during the emergency department
attendance, minimizing the risk of recall bias, and before the
clinical diagnosis; therefore, reporting was not inﬂuenced by
lay interpretation of the usual symptoms associated with
myocardial infarction. Clinician-patient interactions as the
focus of an observation study revealed clinicians actively
restructuring patient accounts until they ﬁt diagnostic criteria
that the clinician felt applicable.24 By using patient-reported
data, accounts of symptom presentation remain as intended
by the source and are not limited to predetermined answers
prompting particular responses as in a questionnaire format.
Table 3. Logistic Regression Model Evaluating Typicality of
Symptoms to Predict the Diagnosis of Myocardial Infarction
OR in Men (95% CI) OR in Women (95% CI)
Unadjusted
Number of typical features
0 or 1 1.0 (reference) 1.0 (reference)
2 1.1 (0.6–1.8) 3.6 (1.0–23.0)
3 1.2 (0.7–2.1) 5.1 (1.5–31.6)
4 1.4 (0.8–2.5) 5.3 (1.5–33.3)
Adjusted*
Number of typical features
0 or 1 1.0 (reference) 1.0 (reference)
2 1.1 (0.6–2.0) 4.0 (1.0–26.1)
3 1.5 (0.9–2.7) 5.9 (1.6–38.0)
4 1.8 (0.9–3.6) 6.9 (1.8–45.3)
Results are odds ratios (ORs) and 95% CIs. Typical features refer to the nature, location,
or radiation of pain and any associated features. Scores of 0 and 1 were combined
because of low numbers.
*Model adjusted for age, history of ischemic heart disease, diabetes mellitus,
hypertension, smoking (current or ex-smoker), ischemia on presentation ECG, and the
presence of any atypical feature.
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The increased reporting of associated symptoms in women
has been widely documented7,9,20,22,25 and conﬁrmed in our
patient population, with radiation to the back, nausea, and
palpitations described more commonly among women. As 93%
of women with myocardial infarction presented with chest pain,
these symptoms occurred as additional symptoms and not
primary presenting symptoms. The presence of these additional
symptoms in women may cloud their symptom presentation,
inﬂuence clinician interpretation of symptoms,7 and provide the
basis for the atypical symptom message to gain dominance.
The limited predictive value of chest pain characteristics in
the absence of other diagnostic information such as ECG has
been conﬁrmed by several studies12,26,27 and could be
responsible for delays in diagnosis. The predictive value of
the combined presence of multiple typical pain features
renders a typical pain presentation in women more diagnos-
tically valuable than in men. The assessment of patients using
symptom clusters may be more clinically relevant than
focusing on symptoms in isolation, as this is often how
patients present. Typical symptom clusters in women should
therefore provoke high suspicion of myocardial infarction.
Recognition of the clinical signiﬁcance of such symptom
clusters may in part address the disparity in treatment and
outcomes experienced by women.20
The National Institute for Health and Care Excellence
guidelines in the United Kingdom state that men and women
with suspected acute coronary syndrome should not be
assessed differently28; this should be extended to interna-
tional guidelines, with a stronger message of the clinical value
of typical symptoms in women. It may be time to reﬂect on
the usefulness of the terms typical and atypical and acknowl-
edge that both men and women with acute coronary
syndrome present with an array of symptoms.25
There are some limitations of our study that may affect the
generalizability of our ﬁndings. We enrolled patients presenting
to a single tertiary care hospital in Scotland. However, our study
population consists of patients who self-presented or were
referred from primary care practitioners to our institution, rather
than those transferred from other acute care hospitals; we
therefore believe our ﬁndings are generalizable to most acute
secondary and tertiary care centers. Participants were identiﬁed
at the time cardiac troponin I testing was ordered in the
emergency department. It is possible that physician bias may
have inﬂuenced the selection of patients who underwent
troponin testing and that those with less typical symptoms
may not have been tested. However, it is widely accepted that
troponin testing is overused in this setting, and that our approach
will have ensured that a broad spectrum of participants was
identiﬁed. Recruitment was restricted to those patients pre-
senting between 8 AM and 3 PM, but we do not anticipate that
patients presenting outside of this time period would be likely to
present with different symptoms. Furthermore, our study was
performed in consenting patients and therefore reﬂects the
presenting symptoms of only those who are able to provide
informed consent. Patients presenting by ambulance with ST-
segment–elevation myocardial infarction bypass the emergency
department to facilitate timely coronary revascularization, and
therefore these patients were not recruited. A recent study
reported sex differences in the presenting symptoms of patients
with ST-segment–elevation myocardial infarction, though it
should be noted that only 24% of the study population were
women.29However, wewould argue that symptomdifferences in
this subgroup are less important, as the diagnosis here is based
primarily on the ECG rather than on other features of the clinical
presentation. Finally, we have not taken into account the effect
that ethnicity may have on symptom presentation. In Scotland,
96% of the population are classiﬁed aswhite,30 and thismay limit
the generalizability of our ﬁndings to other, more ethnically
diverse populations.
Conclusions
Women more frequently describe pain of a typical nature than
do men, and typical symptoms are more predictive of a
diagnosis of myocardial infarction in women than in men. We
advocate that guidelines and educational material be updated
to minimize the risk of underdiagnosis and treatment of
women with myocardial infarction.
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 Table S1. Characteristics of the type 1 myocardial infarction population. 
 Type 1 myocardial infarction 
(n=274) 
 Men Women 
No. of participants, n (%) 184 (15.5) 90 (11.9) 
Age (years), mean (SD) 66.1 (13.1) 72.1 (12.8) 
Past medical history   
  Smoking, n (%) 127 (69) 47 (52.2) 
  Diabetes mellitus, n (%) 39 (21.2) 18 (20.0) 
  Hypertension, n (%) 92 (50.0) 44 (48.9) 
  Hyperlipidaemia, n (%) 81 (44.0) 37 (41.1) 
  Family history, n (%) 85 (46.2) 47 (52.2) 
  Angina, n (%) 68 (37.0) 32 (35.6) 
  Myocardial infarction, n (%) 53 (28.8) 24 (26.7) 
  Previous PCI, n (%) 41 (22.3) 14 (15.6) 
  Ischemic heart disease, n (%) 82 (44.6) 42 (46.7) 
  Previous CABG, n (%) 22 (12.0) 1 (1.1) 
  Heart failure, n (%) 6 (3.3) 2 (2.2) 
  Cerebrovascular disease, n (%) 14 (7.6) 5 (5.6) 
  Peripheral Vascular Disease, n (%) 5 (2.7) 3 (3.3) 
Medications at presentation   
  Aspirin, n (%) 76 (41.3) 30 (33.3) 
  Clopidogrel, n (%) 25 (13.6) 11 (12.2) 
  Prasugrel, n (%) 2 (1.1) 0 (0.0) 
  Ticagrelor, n (%) 1 (0.5) 0 (0.0) 
  Warfarin, n (%) 11 (6.0) 3 (3.3) 
  Betablocker, n (%) 56 (30.4) 24 (26.7) 
  ACE inhibitor or ARB, n (%) 58 (31.5) 32 (35.6) 
  Ca-channel blocker, n (%) 27 (14.7) 17 (18.9) 
  Nitrate, n (%) 49 (26.6) 16 (17.8) 
  Nicorandil, n (%) 9 (4.9) 0 (0.0) 
  Diuretic, n (%) 31 (16.8) 20 (22.2) 
  PPI, n (%) 58 (31.5) 41 (45.6) 
  Statin, n (%) 85 (46.2) 37 (41.1) 
  NOAC, n (%) 0 (0.0) 1 (1.1) 
Electrocardiogram   
  Myocardial ischaemia 61 (33.2) 20 (22.2) 
  ST-segment elevation 11 (6.0) 2 (2.2) 
  ST-segment depression 34 (18.5) 8 (8.9) 
  Left bundle branch block 10 (5.4) 6 (6.7) 
  T-wave inversion 57 (31.0) 26 (28.9) 
Physiological parameters   
  Heart rate (bpm), mean (SD) 72 (20) 77 (18) 
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   Systolic BP (mmHg), mean (SD) 137 (29) 141 (26) 
High-sensitivity cTnI concentration   
  At presentation, ng/L [median, IQR] 94 [3-421] 48 [18-273] 
  At peak, ng/L [median, IQR] 705 [148-3012] 164 [38-1178] 
 Presented as mean (SD), median (inter-quartile range), or number (%). Abbreviations: ACE = angiotensin 
converting enzyme; ARB = angiotensin receptor blockers; CABG = coronary artery bypass grafting; PCI = 
percutaneous coronary intervention; PPI = Proton Pump Inhibitor; NOAC = novel oral anti-coagulants; BP = blood 
pressure.   
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 Table S2. Presenting symptom characteristics stratified by diagnosis. 
 Suspected acute coronary syndrome Type 1 myocardial infarction 
 Men  
(n=1,185) 
Women  
(n=756) 
Men  
(n=184) 
Women 
 (n=90) 
Presenting symptom*     
  Chest pain, n (%) 1081 (91.2) 698 (92.3) 171 (92.9) 84 (93.3) 
  Dyspnoea, n (%) 331 (27.9) 216 (28.6) 58 (31.5) 35 (38.9) 
  Palpitation, n (%) 86 (7.3) 81 (10.7) 3 (1.6) 8 (8.9) 
  Syncope, n (%) 22 (1.9) 8 (1.1) 1 (0.5) 1 (1.1) 
  Other, n (%) 123 (10.4) 65 (8.6) 15 (8.2) 6 (6.7) 
Radiation      
 Left arm, n (%) 368 (31.1) 271 (35.8) 89 (48.4) 44 (48.9) 
 Right arm, n (%) 138 (11.6) 87 (11.5) 50 (27.2) 21 (23.3) 
 Neck/jaw, n (%) 234 (19.7) 212 (28.0)  41 (22.3) 29 (32.2) 
 Back, n (%) 196 (16.5) 237 (31.3)  29 (15.8) 25 (27.8) 
 Other, n (%) 81 (6.8) 55 (7.3) 9 (4.9) 8 (8.9) 
Additional symptoms     
 Nausea, n (%) 262 (22.1) 257 (34.0) 35 (19.0) 30 (33.3) 
 Vomiting, n (%) 41 (3.5) 34 (4.5)  6 (3.3) 3 (3.3) 
 Sweating, n (%) 371 (31.3) 229 (30.3) 58 (31.5) 29 (32.2) 
 Shortness of breath, n (%) 225 (19.0) 126 (16.7) 28 (15.2) 21 (23.3) 
 Palpitations, n (%) 38 (3.2) 29 (3.8) 3 (1.6) 4 (4.4) 
 Other, n (%) 54 (4.6) 35 (4.6) 7 (3.8) 1 (1.1) 
Symptom feature     
  Typical nature†, n (%) 772 (65.1) 532 (70.4) 117 (63.6) 73 (81.1)  
  Typical location‡, n (%) 1068 (90.1) 683 (90.3) 165 (89.7) 84 (93.3) 
  Radiation (any), n (%) 586 (49.5) 491 (64.9)  119 (64.7) 65 (72.2) 
  Additional symptoms, n (%) 657 (55.4) 456 (60.3) 94 (51.1) 56 (62.2) 
Symptom classification     
 Typical pain§ 719 (61) 489 (65) 109 (59) 69 (77) 
 Atypical pain|| 466 (39) 267 (35) 75 (41) 21 (23) 
 
* Patient reporting more than one symptom were counted for all symptoms reported 
† Typical nature is pain with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing or gripping  
‡ Typical location is chest, arm or jaw  
§ Typical pain classified in any patient who described pain of chest, arm or jaw, with descriptors of dull, heavy, tight, 
pressure, ache, squeezing, crushing or gripping.  
|| Atypical pain classified in any patient who described epigastric or back pain, or pain that was burning, stabbing, 
indigestion like, or any other pain description, or presentation.
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 Table S3. Comparison of symptom features in all men and women with a diagnosis of type 1 and type 2 myocardial infarction stratified 
by sex.  
 
 
 Type 1 myocardial infarction Type 2 myocardial infarction  
p-value  
(All Type 1 
vs Type 2) 
 All 
patients  
(n=274) 
Men 
 (n=184) 
Women 
 (n=90) 
All 
patients 
(n=77) 
Men 
(n=38) 
Women 
(n=39) 
Presenting symptom*        
  Chest pain, n (%) 255 (93) 171 (93) 84 (93) 65 (84) 33 (87) 32 (82) 0.03 
  Dyspnoea, n (%) 93 (34) 58 (32) 35 (39) 30 (39) 16 (45) 14 (36) 0.50 
  Palpitation, n (%) 11 (4) 3 (2) 8 (9) 15 (19) 6 (16) 9 (23) <0.001 
  Syncope, n (%) 2 (1) 1 (1) 1 (1) 6 (8) 4 (11) 2 (5) 0.001 
  Other, n (%) 21 (7) 15 (8) 6 (7) 4 (5) 1 (3) 3 (8) 0.62 
Symptom feature        
  Typical nature†, n (%) 190 (69) 117 (64) 73 (81) 51 (66) 23 (61) 28 (72) 0.70 
  Typical location‡, n (%) 249 (91) 165 (90) 84 (93) 63 (82) 31 (82) 32 (82) 0.04 
  Radiation (any), n (%) 184 (67) 119 (65) 65 (72) 38 (49) 17 (45) 21 (54) 0.006 
  Associated symptoms, n (%) 150 (55) 94 (51) 56 (62) 44 (57) 21 (55)  23 (59) 0.81 
Symptom classification        
 Typical pain§ 178 (65) 109 (59) 69 (77) 45 (58) 21 (55) 24 (62) 0.36 
 Atypical pain|| 96 (35) 75 (41) 21 (23) 32 (42) 17 (45) 15 (38)  
 
* Patient reporting more than one symptom were counted for all symptoms reported 
† Typical nature is pain with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing or gripping  
‡ Typical location is chest, arm or jaw  
§ Typical pain classified in any patient who described pain of chest, arm or jaw, with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing or gripping.  
|| Atypical pain classified in any patient who described epigastric or back pain, or pain that was burning, stabbing, indigestion like, or any other pain description, or presentation.
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 Table S4. Comparison of symptom features in all men and women with a diagnosis of type 1 myocardial infarction and those reclassified 
using a high-sensitivity cardiac troponin test and sex-specific diagnostic thresholds. 
 
 Patient reported symptoms in those with type 1 myocardial infarction 
 Men Women 
 All  
 
 
(n=184) 
Reclassified 
by hs-cTnI 
assay#  
(n=9) 
Identified 
by c-TnI 
assay 
(n=175) 
All  
 
 
(n=90) 
Reclassified 
by hs-cTnI 
assay# 
(n=27) 
Identified 
by c-TnI 
assay 
(n=63) 
Presenting symptom*       
  Chest pain, n (%) 171 (93) 9 (100) 162 (93) 84 (93) 24 (89) 60 (95) 
  Dyspnoea, n (%) 58 (32) 5 (56) 53 (30) 35 (39) 8 (30) 27 (43) 
  Palpitation, n (%) 3 (2) 0 (0) 3 (2) 8 (9) 3 (11) 5 (8) 
  Syncope, n (%) 1 (1) 0 (0) 1 (1) 1 (1) 0 (0) 1 (2) 
  Other, n (%) 15 (8) 1 (11) 14 (8) 6 (7) 2 (7) 4 (6) 
Symptom feature       
  Typical nature†, n (%) 117 (64) 4 (44) 113 (65) 73 (81) 21 (78) 52 (83) 
  Typical location ‡,n (%) 165 (90) 9 (100) 156 (89) 84 (93) 25 (93) 59 (94) 
  Radiation, n (%) 119 (65) 4 (44) 115 (66) 65 (72) 17 (63) 48 (76) 
  Additional symptoms, n (%) 94 (51) 4 (44) 90 (51) 56 (62) 17 (63) 39 (62) 
Symptom classification       
  Typical pain, § n (%) 109 (59) 4 (44) 105 (60) 69 (77) 20 (74) 49 (78) 
  Atypical pain, || n (%) 75 (41) 5 (56) 70 (40) 21 (23) 7 (26) 14 (22) 
* Patient reporting more than one symptom were counted for all symptoms reported 
† Typical nature is pain with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing or gripping  
‡ Typical location is chest, arm or jaw  
§ Typical pain classified in any patient who described pain of chest, arm or jaw, with descriptors of dull, heavy, tight, pressure, ache, squeezing, crushing or gripping.  
|| Atypical pain classified in any patient who described epigastric or back pain, or pain that was burning, stabbing, indigestion like, or any other pain description, or 
presentation 
# Participants diagnosed with myocardial injury identified by the high sensitivity assay with sex-specific thresholds (>16ng/L for women and >34ng/L for men) who would 
have been unrecognised with the previous generation of contemporary cardiac troponin I assays (those with high-sensitivity troponin I concentrations of 17-49ng/L for 
women and 35-49ng/L for men) were “reclassified”.
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 Figure S1. HighSTEACS suspected acute coronary syndrome symptom checklist. 
 
Presenting symptom 
Chest pain  SOB  Palpitations  Collapse  Other__________  
Quality, severity and duration of pain 
Nature of pain  Radiation  Associated 
symptoms 
 Severity and duration 
Tight  Left arm  Nausea/Vomiting  pain score/10 ___________ 
Dull  Right arm  Sweating  Duration of pain _________minutes 
Squeezing  Back  Palpitations   No. of episodes in 24hr___________ 
Gripping  Jaw/neck  SOB   
Ache  Other_________  Collapse  
Crushing   Other________  
Heavy   
Pressure  
Sharp  
Stabbing  
Hot  
Burning  
Indigestion  
Other________  
Pain characteristics 
Worse on changing position for example sitting up or turning to the side Yes/ No 
Worse on palpation Yes/ No  
Worse on exertion (e.g. climbing stairs) Yes/ No 
Better with rest Yes/ No 
Better with nitrates Yes/ No 
Worse on changing position for example sitting up or turning to the side Yes/ No 
Is the pain intermittent/discrete/continuous?  
If previous myocardial infarction or known angina: similar / worse / different / na 
Location 
Central Chest Yes/ No Mark with an ‘X’ areas where pain is present 
Left chest Yes/ No  
Right chest Yes/ No 
Arm Yes/ No 
Jaw Yes/ No 
Epigastric Yes/ No 
Abdominal Yes/ No 
Other_______________ Yes/No 
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